Peripheral I.V. Catheter Market Size, Share, Growth, and Industry Analysis, Types (Short PIVC, Integrated/Closed PIVC), Applications (Hospitals, Ambulatory Surgical Centers, Clinics, Home Use, Others), and Regional Insights and Forecast to 2035
- Last Updated: 22-May-2026
- Base Year: 2025
- Historical Data: -
- Region: Global
- Format: PDF
- Report ID: GGI125590
- SKU ID: 30293879
- Pages: 114
Peripheral I.V. Catheter Market Size
Global Peripheral I.V. Catheter Market size was USD 3.82 Billion in 2025 and is projected to touch USD 4.01 Billion in 2026, USD 4.21 Billion in 2027, and USD 6.24 Billion by 2035, exhibiting a CAGR of 5.03% during the forecast period (2026-2035). Around 49% of growth is linked to hospital demand, while 28% comes from outpatient and ambulatory treatment expansion.
![]()
US Peripheral I.V. Catheter Market growth remains stable due to surgical volume, emergency care demand, and strong use of safety devices. Around 57% of hospitals prioritize premium safety catheters. Nearly 39% of contracts include integrated systems, while 26% of demand comes from outpatient infusion and recovery care.
Key Findings
- Market Size: Valued at $3.82Bn in 2025, projected to touch $4.01Bn in 2026 to $6.24Bn by 2035 at a CAGR of 5.03%.
- Growth Drivers: Around 49% hospital demand, 44% infection focus, 31% safer insertion need, 28% outpatient growth.
- Trends: Nearly 51% safety launches, 43% blood control demand, 37% comfort materials, 32% visibility upgrades.
- Key Players: Becton Dickinson (BD), B. Braun Melsungen, Terumo Corporation, Teleflex, Medline Industries.
- Regional Insights: North America 34%, Asia-Pacific 30%, Europe 27%, Middle East & Africa 9%, led by hospital demand.
- Challenges: Around 38% training gaps, 33% replacement issues, 27% insertion difficulty, 22% pricing pressure.
- Industry Impact: Nearly 46% premium shift, 39% integrated demand, 31% stabilization focus, 24% home care expansion.
- Recent Developments: About 18% tender gains, 17% inquiry rise, 16% stronger demand, 15% channel growth.
A unique feature of the Peripheral I.V. Catheter Market is that small design changes can strongly affect nurse workflow and patient comfort. Around 35% of clinicians value easier securement and visibility more than added features. Products that save seconds during insertion can create major value at scale.
Peripheral I.V. Catheter Market Trends
The Peripheral I.V. Catheter Market is growing steadily as hospitals and clinics continue to depend on intravenous access for fluids, medicines, emergency care, and diagnostic procedures. Peripheral I.V. catheters remain one of the most widely used medical devices in patient care because they are fast to place and suitable for short-term therapy. Around 68% of admitted patients require some form of peripheral vascular access during treatment. Nearly 54% of healthcare buyers now prefer safety-engineered catheter designs that reduce needle-stick risk. About 47% of facilities prioritize catheters with better stabilization features to lower accidental dislodgement. Integrated closed systems are gaining traction, with close to 36% of new procurement demand focused on infection control benefits. Nearly 42% of outpatient procedures use short-term catheter access for medicine delivery and hydration support. Pediatric and elderly care settings are increasing demand for smaller gauge products. Around 31% of healthcare providers now emphasize single-attempt insertion success when choosing products. The Peripheral I.V. Catheter Market is also supported by rising surgeries, emergency visits, and expansion of home-based infusion services.
Peripheral I.V. Catheter Market Dynamics
Growth in outpatient and home infusion care
Short-stay treatment centers and home infusion programs are creating fresh demand for easy-to-use catheter products. Around 44% of ambulatory procedures need temporary IV access. Nearly 29% of home therapy providers prefer user-friendly catheter kits with improved safety and secure dressing compatibility.
Rising demand for safe vascular access
Increasing patient volume and stronger infection control standards continue to drive demand. Around 59% of healthcare facilities prioritize catheter safety features. Nearly 46% seek products that improve first-stick success, while 34% focus on reducing replacement frequency and line complications.
RESTRAINTS
"Complications and replacement rates"
Peripheral IV lines can fail due to infiltration, phlebitis, or accidental removal. Around 33% of providers cite premature replacement as a workflow issue. Nearly 27% report higher material use when multiple insertion attempts are needed. These factors can affect efficiency and patient comfort.
CHALLENGE
"Training consistency and difficult vein access"
Successful catheter insertion depends on staff skill and patient vein condition. Around 38% of facilities identify training consistency as a challenge. Nearly 25% of difficult-access patients require multiple attempts. Improving technique, visualization tools, and standardized protocols remains important.
Segmentation Analysis
The Global Peripheral I.V. Catheter Market size was USD 3.82 Billion in 2025 and is projected to touch USD 4.01 Billion in 2026, USD 4.21 Billion in 2027, and USD 6.24 Billion by 2035, exhibiting a CAGR of 5.03% during the forecast period (2026-2035). Market growth is supported by rising hospital admissions, surgical procedures, and outpatient care demand. Type demand is led by hospitals and clinics, while application demand is strongest in short PIVC products with growing interest in integrated closed systems.
By Type
Hospitals
Hospitals remain the leading end-use segment because emergency rooms, inpatient wards, intensive care units, and operating rooms use large volumes of peripheral catheters every day. Strong patient throughput and strict safety procurement policies support steady demand.
Hospitals held the largest share in the Peripheral I.V. Catheter Market, accounting for USD 1.76 Billion in 2026, representing 44% of the total market. This segment is expected to grow at a CAGR of 5.2% from 2026 to 2035, driven by admissions growth, surgeries, and acute care demand.
Ambulatory Surgical Centers
Ambulatory surgical centers use peripheral IV catheters for same-day procedures, anesthesia delivery, and recovery care. Fast turnover and short treatment duration make reliable short-term access products highly important.
Ambulatory Surgical Centers accounted for USD 0.68 Billion in 2026, representing 17% of the total market. This segment is expected to grow at a CAGR of 5.4% from 2026 to 2035, supported by outpatient surgery expansion.
Clinics
Clinics use catheters for hydration therapy, antibiotics, injections, and diagnostic procedures. Demand is increasing as community healthcare centers expand treatment capacity and patient convenience services.
Clinics accounted for USD 0.72 Billion in 2026, representing 18% of the total market. This segment is expected to grow at a CAGR of 5.0% from 2026 to 2035, driven by primary care and day treatment growth.
Home Use
Home use is expanding with home infusion therapy, post-discharge medication support, and elder care services. Easy handling and safety-focused catheter systems are especially important in this segment.
Home Use accounted for USD 0.48 Billion in 2026, representing 12% of the total market. This segment is expected to grow at a CAGR of 5.6% from 2026 to 2035, supported by remote care trends and aging populations.
Others
Other end users include specialty centers, military care units, urgent care clinics, and mobile healthcare services where temporary vascular access remains essential.
Others accounted for USD 0.37 Billion in 2026, representing 9% of the total market. This segment is expected to grow at a CAGR of 4.8% from 2026 to 2035, supported by diversified treatment settings.
By Application
Short PIVC
Short PIVC products dominate the market because they are commonly used for hydration, medications, blood sampling support, and routine short-term therapy in nearly all healthcare settings.
Short PIVC held the largest share in the Peripheral I.V. Catheter Market, accounting for USD 2.97 Billion in 2026, representing 74% of the total market. This segment is expected to grow at a CAGR of 4.9% from 2026 to 2035, driven by routine hospital use and high patient volumes.
Integrated/Closed PIVC
Integrated or closed PIVC systems are gaining popularity because they support better infection control, cleaner blood management, and reduced exposure risk for healthcare staff.
Integrated/Closed PIVC accounted for USD 1.04 Billion in 2026, representing 26% of the total market. This segment is expected to grow at a CAGR of 5.5% from 2026 to 2035, driven by safety standards and premium product adoption.
Peripheral I.V. Catheter Market Regional Outlook
The Global Peripheral I.V. Catheter Market size was USD 3.82 Billion in 2025 and is projected to touch USD 4.01 Billion in 2026, USD 4.21 Billion in 2027, and USD 6.24 Billion by 2035, exhibiting a CAGR of 5.03% during the forecast period (2026-2035). Regional demand is supported by hospital admissions, surgical volume, outpatient treatment growth, and stronger infection prevention standards. Mature healthcare systems lead premium product adoption, while developing regions expand through rising access to clinical care.
North America
North America remains the largest regional market due to advanced hospital networks, high procedure volume, and broad use of safety-engineered devices. Around 61% of facilities prioritize needlestick prevention products. Nearly 46% of demand comes from inpatient treatment and emergency care, while outpatient therapy also continues to expand.
North America held the largest share in the Peripheral I.V. Catheter Market, accounting for USD 1.36 Billion in 2026, representing 34% of the total market. This region is expected to grow at a CAGR of 4.9% from 2026 to 2035, driven by hospital procurement, safety standards, and aging population demand.
Europe
Europe is a strong market supported by universal healthcare systems, infection control protocols, and growing day-care procedures. Around 43% of buyers prefer integrated catheter systems. Nearly 35% of regional demand comes from surgical recovery and chronic treatment settings.
Europe accounted for USD 1.08 Billion in 2026, representing 27% of the total market. This region is expected to grow at a CAGR of 4.8% from 2026 to 2035, supported by patient safety focus, public healthcare spending, and outpatient growth.
Asia-Pacific
Asia-Pacific is the fastest growing region due to expanding hospitals, rising healthcare access, and increasing surgical procedures. Around 52% of purchases are volume-driven standard catheter products. Nearly 38% of demand comes from urban hospitals and growing private healthcare chains.
Asia-Pacific accounted for USD 1.20 Billion in 2026, representing 30% of the total market. This region is expected to grow at a CAGR of 5.7% from 2026 to 2035, driven by healthcare expansion, population growth, and higher treatment capacity.
Middle East & Africa
Middle East & Africa is expanding through hospital modernization, private healthcare growth, and broader access to emergency treatment. Around 31% of purchases come from public hospitals, while 26% are linked to new specialty clinics and surgical centers.
Middle East & Africa accounted for USD 0.36 Billion in 2026, representing 9% of the total market. This region is expected to grow at a CAGR of 5.2% from 2026 to 2035, supported by infrastructure upgrades and healthcare investment.
List of Key Peripheral I.V. Catheter Market Companies Profiled
- B. Braun Melsungen
- Smith Medical
- Becton Dickinson (BD)
- Medline Industries
- Terumo Corporation
- Bard Acess
- Tangent Medical
- C.R. Bard
- Argon Healthcare
- Teleflex
- Vascular Pathways
Top Companies with Highest Market Share
- Becton Dickinson (BD): Holds about 21% share through broad hospital reach, safety devices, and strong global distribution.
- B. Braun Melsungen: Holds about 15% share supported by premium vascular access portfolio and clinical trust.
Investment Analysis and Opportunities in Peripheral I.V. Catheter Market
The Peripheral I.V. Catheter Market offers stable investment potential because catheter use remains essential across hospitals, clinics, and ambulatory centers. Around 48% of investors prefer companies with recurring institutional contracts and strong hospital relationships. Nearly 39% of new investment interest targets safety catheters and integrated closed systems that help reduce contamination risk. About 34% of expansion plans focus on Asia-Pacific where healthcare infrastructure is growing quickly. Home infusion services create another opportunity, with around 27% of patients preferring treatment outside hospitals when possible. Nearly 31% of procurement teams seek products with better stabilization and fewer replacement events. Manufacturers with reliable sterile production, regulatory strength, and broad clinical portfolios are likely to attract the strongest long-term investor attention.
New Products Development
Manufacturers are launching improved Peripheral I.V. Catheter products focused on insertion success, patient comfort, and infection prevention. Around 51% of recent launches include passive safety needle protection. Nearly 43% feature integrated blood control technology to reduce exposure risk. About 37% of new designs focus on softer catheter materials that improve dwell comfort. Transparent hubs and better flashback visibility are included in around 32% of recent products. Nearly 28% of suppliers now offer pediatric and difficult-vein-access variants. Digital training kits and insertion guidance tools are also increasing. Product development is clearly moving toward safer handling, easier placement, and reduced complications.
Recent Developments
- Becton Dickinson (BD): Expanded safety catheter portfolio with upgraded passive shield features, helping hospital tender wins rise by nearly 18% during 2025.
- B. Braun Melsungen: Introduced comfort-focused catheter materials and improved stabilization options, supporting around 16% stronger demand from acute care buyers in 2025.
- Terumo Corporation: Enhanced thin-wall catheter flow performance for faster infusion efficiency, resulting in nearly 14% higher distributor orders during 2025.
- Teleflex: Expanded integrated blood control catheter range and recorded close to 17% more inquiries from infection-sensitive healthcare facilities in 2025.
- Medline Industries: Strengthened private-label supply programs for clinics and outpatient centers, helping about 15% growth in channel volume sales during 2025.
Report Coverage
This report covers the complete Peripheral I.V. Catheter Market structure, including product demand, healthcare usage trends, regional performance, and competitive positioning. It studies catheter use across hospitals, ambulatory surgical centers, clinics, home care, and specialty treatment settings. Around 62% of routine inpatient therapies require some form of peripheral access, highlighting the essential nature of this device category. The report reviews product segments such as short PIVC and integrated or closed PIVC systems. Regional analysis explains why North America leads premium safety adoption while Asia-Pacific expands through hospital capacity growth. Nearly 44% of healthcare buyers prioritize infection prevention, while 36% focus on insertion success and lower replacement rates. The report also evaluates procurement behavior, tender systems, private-label expansion, and premium versus standard product positioning. Innovation trends such as passive safety shielding, blood control features, softer catheter materials, and improved stabilization systems are examined in detail. Competitive profiling includes global leaders, specialized vascular access companies, and regional suppliers. Risks such as pricing pressure, training gaps, and complication management are also included. The report supports manufacturers, distributors, hospital buyers, investors, and healthcare planners seeking clear market direction.
Peripheral I.V. Catheter Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 3.82 Billion in 2026 |
|
|
Market Size Value By |
USD 6.24 Billion by 2035 |
|
|
Growth Rate |
CAGR of 5.03% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Peripheral I.V. Catheter Market expected to touch by 2035?
The global Peripheral I.V. Catheter Market is expected to reach USD 6.24 Billion by 2035.
-
What CAGR is the Peripheral I.V. Catheter Market expected to exhibit by 2035?
The Peripheral I.V. Catheter Market is expected to exhibit a CAGR of 5.03% by 2035.
-
Who are the top players in the Peripheral I.V. Catheter Market?
B. Braun Melsungen, Smith Medical, Becton Dickinson (BD), Medline Industries, Terumo Corporation, Bard Acess, Tangent Medical, C.R. Bard, Argon Healthcare, Teleflex, Vascular Pathways
-
What was the value of the Peripheral I.V. Catheter Market in 2025?
In 2025, the Peripheral I.V. Catheter Market value stood at USD 3.82 Billion.
Our Clients
Download FREE Sample